Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
China Just Got Another Cheap EV America Would Love to Have - 221 Things You Ought to Never Tell Your Childless Companion
- 3Sudan war ‘being fought on women’s bodies’: Survivors detail sexual assault
- 4This Week In Space podcast: Episode 192 — Space, 2026!
- 5The most effective method to Amplify Your Opportunity for growth in a Web-based Degree Program
- EU delegation urges China to tighten export controls
- Grasping the Elements of Medical caretaker Pay rates: Factors That Shape Your Pay
- Telescope in Chile captures stunning new picture of a cosmic butterfly
- Figure out How to Really focus on Your Dental Inserts for Durable Outcomes
- Blood pressure drug recalled for possible cross-contamination
- German foreign minister backs abandoning EU's unanimity principle
- What's your #1 tone
- German petrol stations hike prices as once-a-day rule takes effect
- Faulty glucose monitors linked to 7 deaths and more than 700 injuries, FDA warns
